Kidney Cancer

Aravive Highlights Updated Batiraxcept Data From Kidney Cancer Trial

Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer

Merck's Keytruda Scores First Approval In Adjuvant Kidney Cancer Setting

Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer

Merck's Keytruda Scores First Approval In Adjuvant Kidney Cancer Setting

See Why Sonnet BioTherapeutics Stock Is Skyrocketing In Premarket Tuesday

Arrowhead's ARO-HIF2 Shows Early Signs Of Efficacy In Type Of Kidney Cancer

See Why Sonnet BioTherapeutics Stock Is Skyrocketing In Premarket Tuesday

Arrowhead's ARO-HIF2 Shows Early Signs Of Efficacy In Type Of Kidney Cancer

Merck's Keytruda Shows Clinical Benefit in Post-Surgery Kidney Cancer Setting

Merck's Keytruda Shows Better Disease-Free Survival As Adjuvant Therapy In Kidney Cancer

Kidney Cancer Recent News

Merck's Belzutifan Wins Priority Review Status In Type Of Kidney Cancer

The FDA has granted Priority Review designation to Merck & Co (NYSE:

Aveo Pharma's Tivozanib To Be Tested In Combination With Opdivo In Kidney Cancer

AVEO Pharmaceuticals Inc (NASDAQ: AVEO) has

Aveo Pharma's Stock Trading Higher On Much Awaited FDA Approval For Tivozanib In Relapsed Kidney Cancer

The FDA has finally approved AVEO Pharmaceuticals Inc’s</

European Medicines Agency's CHMP Backs Approval Of Cabometyx/Opdivo Combo In Kidney Cancer

Merck/Eisai's Keytruda-Lenvima Combo Tops Standard Of Care In Late-Stage Kidney Cancer Study

Exelixis' Cabozantinib Data Shows Clinically Significant Benefit Versus Pfizer's Sutent, In A Type Of Kidney Cancer